Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery
Authors:
- 3 August 2018
- journal article
- review article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 41 (8) , 797-814
Abstract
With the current advance in nanotechnology, the development has accelerated of a number of nanoparticle-type drugs such as nano-emulsions, lipid emulsions, liposomes, and cell therapeutics. With these developments, attempts are being made to apply these new drugs to healing many intractable diseases related to antibody production, autoimmune disorders, cancer, and organ transplantation in both clinical and nonclinical trials. Drug delivery to the lymphatic system is indispensable for treating these diseases, but the core technologies related to the in vivo distribution characteristics and lymphatic delivery evaluation of these particle-type drugs have not yet been established. Additionally, the core technologies for setting up the pharmacotherapeutic aspects such as their usage and dosages in the development of new drugs do not meet the needs of the market. Therefore, it is necessary to consider dividing these particle-type drugs into soft-lipid nanoparticles that can change size in the process of body distribution and hard-lipid nanoparticles whose surfaces are hardened and whose sizes do not easily change in vivo; these soft- and hard-lipid nanoparticles likely possess different biodistribution characteristics including delivery to the lymphatic system. In this review, we summarize the different types, advantages, limitations, possible remedies, and body distribution characteristics of soft- and hard-lipid nanoparticles based on their administration routes. We also emphasize that it will be necessary to fully understand the differences in distribution between these soft- and hard-lipid nanoparticle-type drugs and to establish pharmacokinetic models for their more ideal lymphatic delivery.Keywords
Funding Information
- the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2017RIDIAB04035667)
This publication has 135 references indexed in Scilit:
- Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A ReviewJournal of Drug Delivery, 2013
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapyDiscover Nano, 2011
- Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticlesAdvanced Drug Delivery Reviews, 2011
- Injectable Lipid Emulsions—Advancements, Opportunities and ChallengesAAPS PharmSciTech, 2010
- Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapiesExpert Opinion on Drug Delivery, 2009
- Doxorubicin‐Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double‐Targeting Folate Receptor and Early Endosomal pHSmall, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulationsInternational Journal of Pharmaceutics, 2008